Andrés
Castellanos Martín
Investigador en el periodo 2011-2015
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (11)
2023
2020
-
Stromal SNAI2 is required for ERBB2 breast cancer progression
Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230
2018
-
Supplementary data for the biological age linked to oxidative stress modifies breast cancer aggressiveness
Data in Brief
-
The biological age linked to oxidative stress modifies breast cancer aggressiveness
Free Radical Biology and Medicine, Vol. 120, pp. 133-146
2017
-
Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma
British Journal of Dermatology, Vol. 176, Núm. 5, pp. 1279-1287
-
MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma
British Journal of Dermatology, Vol. 177, Núm. 1, pp. 168-178
2015
-
A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development
Oncogene, Vol. 34, Núm. 36, pp. 4777-4790
-
Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach
Genome Biology, Vol. 16, Núm. 1
2013
2012
-
Multiple Novel Alternative Splicing Forms of FBXW7α Have a Translational Modulatory Function and Show Specific Alteration in Human Cancer
PLoS ONE, Vol. 7, Núm. 11
-
New models towards assessing anti-cancer therapeutics
Histology and Histopathology, Vol. 27, Núm. 2, pp. 157-170